Su1054 Ns3 Q80k Did Not Impact Efficacy or...

Gastroenterology 2014 / 05 Vol. 146; Iss. 5

Su1054 Ns3 Q80k Did Not Impact Efficacy or Treatment-Emergent Resistance Patterns in HCV Genotype-1-Infected Patients Receiving Faldaprevir Plus Pegylated Interferon/Ribavirin in Three Phase III Trials

Berger, Kristi, Sarrazin, Christoph, Ferenci, Peter, Jensen, Donald M., Jacobson, Ira M., Stern, Jerry O., Quinson, Anne-Marie, Scherer, Joseph, Kukolj, George
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
146
Language:
english
Journal:
Gastroenterology
DOI:
10.1016/S0016-5085(14)63545-9
Date:
May, 2014
File:
PDF, 396 KB
english, 2014
Conversion to is in progress
Conversion to is failed